16/07/2026
Antithrombotic Drugs
1. Heparin / Low-Molecular-Weight Heparins
Drugs
Heparin
Low-molecular-weight heparins
Enoxaparin
Dalteparin
Therapeutic Uses
Acute coronary syndromes
Percutaneous coronary interventions
Mechanism / Clinical Pearls
Endogenous polysaccharide, inhibits thrombin (factor IIa) and factor Xa in an antithrombin III–dependent manner
Parenteral use only
Heparin: short t½, complex pharmacokinetics, low bioavailability after subcutaneous injection
Low-molecular-weight heparin: longer half-life, renal excretion; accumulation in renal insufficiency
Heparin-induced thrombocytopenia
2. Fondaparinux
Drug
Fondaparinux
Therapeutic Uses
Acute coronary syndromes
Percutaneous coronary interventions
Mechanism / Clinical Pearls
Synthetic pentasaccharide, antithrombin III–dependent, factor Xa inhibitor
Most favorable efficacy-safety ratio
3. Bivalirudin / Lepirudin
Drugs
Bivalirudin
Lepirudin
Therapeutic Uses
Percutaneous coronary interventions (bivalirudin)
Heparin-induced thrombocytopenia (HIT II) recombinant lepirudin
Mechanism / Clinical Pearls
Direct thrombin (factor IIa) inhibitors
Parenteral use only
Advantage of bivalirudin over heparin unclear